Doctor profile · Federal record
Dr. Ryan Valicek, M.D.
Rheumatology Physician (CMS: Rheumatology) · Internal Medicine Physician · Sugar Land, TX
- NPI 1386817039
- Accepts Medicare
- MIPS 95.5 / 100 · 2023
- 21 yrs in practice
- Licensed in 2 states
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
7616 Branford Pl Ste 320
Sugar Land, TX 774793794
(281) 980-1742 - Mailing address
-
Po Box 18103
Sugar Land, TX 774968103
Credentials & registration
- NPI registered
- April 2008 — 18 yrs on file
- Profile last updated
- September 27, 2021
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- Texas #N7506 · Missouri #2005017763
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1386817039. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
57,843
Distinct HCPCS
10
Medicare allowed
$1,213,893
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 20,913 | 11 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 18,050 | 27 | $13 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 13,927 | 34 | $42 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 3,410 | 18 | $33 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 667 | 295 | $124 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 443 | 93 | $126 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 121 | 24 | $27 | |
96375 |
Injection of additional new drug or substance into vein | 104 | 24 | $15 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 75 | 18 | $70 | |
J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg | 68 | 17 | $4 |
In context: peer comparison
Among 5 peers in Sugar Land Rheumatology Physician, average services per provider: 1,356. This provider delivers 43× the peer median.Open Payments
Industry payments received
All-time total
$4,881
Transactions
141
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 10 | $1,917.51 | |
| Amgen INC. | 26 | $562.32 | |
| Ucb, INC. | 16 | $472.35 | |
| Abbvie INC. | 23 | $388.70 | |
| AstraZeneca Pharmaceuticals Lp | 16 | $338.88 | |
| Pfizer INC. | 19 | $321.34 | |
| Genzyme Corporation | 5 | $138.49 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 4 | $112.26 | |
| Lilly USA, LLC | 4 | $92.40 | |
| Novartis Pharmaceuticals Corporation | 6 | $90.16 | |
| Fresenius Kabi USA, LLC | 3 | $69.61 | |
| Alexion Pharmaceuticals, INC. | 3 | $67.51 | |
| Mallinckrodt Hospital Products INC. | 2 | $52.09 | |
| Aurinia Pharma U.S., INC. | 2 | $45.34 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $39.98 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,379
Patients
427
Total drug cost
$857,410
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 326 | 108 | $17,750 |
| Prednisone | Generic | 321 | 119 | $2,274 |
| Methotrexate (Methotrexate Sodium) | Brand | 201 | 68 | $8,329 |
| Leflunomide | Generic | 87 | 30 | $7,121 |
| Sulfasalazine | Generic | 74 | 32 | $2,366 |
| Leucovorin Calcium | Generic | 71 | 20 | $1,125 |
| Gabapentin | Generic | 41 | 12 | $730 |
| Enbrel Sureclick (Etanercept) | Brand | 38 | 0 | $268,329 |
| Rinvoq (Upadacitinib) | Brand | 38 | 11 | $289,032 |
| Humira(Cf) Pen (Adalimumab) | Brand | 37 | 0 | $258,043 |
Hospital affiliations
Frequently asked questions
What is Dr. Ryan Valicek's medical specialty?
Dr. Ryan Valicek practices Rheumatology Physician in Sugar Land, TX.
Where does Dr. Ryan Valicek practice?
Dr. Ryan Valicek practices at 7616 Branford Pl Ste 320, Sugar Land, TX 774793794. Office phone: 2819801742.
What is Dr. Ryan Valicek's NPI?
Dr. Ryan Valicek's National Provider Identifier (NPI) is 1386817039, issued by NPPES.
Does Dr. Ryan Valicek accept Medicare assignment?
Yes. Dr. Ryan Valicek accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ryan Valicek commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.